ES2119992T3 - Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). - Google Patents
Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).Info
- Publication number
- ES2119992T3 ES2119992T3 ES94900935T ES94900935T ES2119992T3 ES 2119992 T3 ES2119992 T3 ES 2119992T3 ES 94900935 T ES94900935 T ES 94900935T ES 94900935 T ES94900935 T ES 94900935T ES 2119992 T3 ES2119992 T3 ES 2119992T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- mgmt
- hybridoma ecacc
- nov
- date jun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
EL PRESENTE INVENTO PROPORCIONA ANTICUERPOS CAPACES DE DISCRIMINAR ENTRE MGMT HUMANO Y UNA FORMA ALQUILATADA DE LUGAR ACTIVO DE ESTA ENZIMA EN UN PROCEDIMIENTO DE INMUNOPRECIPITACION. LOS ANTICUERPOS MONOCLONALES CON ESTA CAPACIDAD DE DISCRIMINACION SE OBTIENEN DE HIBRIDOMA ECACC 92112510 E HIBRIDOMA ECACC 93112514, QUE FUERON DEPOSITADOS EN LA COLECCION EUROPEA DE CULTIVOS DE CELULAS ANIMALES, REINO UNIDO BAJO EL TRATADO DE BUDAPEST EN 25 DE NOVIEMBRE DE 1992 Y 25 DE NOVIEMBRE DE 1993, RESPECTIVAMENTE. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 92112510 SE HA DENOMINADO MAB 5H7. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 93112514 SE HA LLAMADO MAB 3C7.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929224888A GB9224888D0 (en) | 1992-11-27 | 1992-11-27 | Monoclonal antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2119992T3 true ES2119992T3 (es) | 1998-10-16 |
Family
ID=10725777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94900935T Expired - Lifetime ES2119992T3 (es) | 1992-11-27 | 1993-11-29 | Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). |
Country Status (10)
Country | Link |
---|---|
US (1) | US5817514A (es) |
EP (1) | EP0670908B1 (es) |
AT (1) | ATE169680T1 (es) |
AU (1) | AU688289B2 (es) |
CA (1) | CA2149867A1 (es) |
DE (1) | DE69320364T2 (es) |
ES (1) | ES2119992T3 (es) |
GB (1) | GB9224888D0 (es) |
SG (1) | SG48841A1 (es) |
WO (1) | WO1994012660A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407804A (en) * | 1992-05-22 | 1995-04-18 | Applied Genetics Inc. | Assays for O6 -methylguanine-DNA methyltransferase |
WO2002027019A1 (en) * | 2000-09-29 | 2002-04-04 | The Johns Hopkins University School Of Medicine | Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
NZ528594A (en) * | 2001-04-10 | 2005-07-29 | Ecole Polytech | Methods using O6-alkylguanine-DNA alkyltransferases |
JP2009523813A (ja) | 2006-01-18 | 2009-06-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌を治療するためにインテグリンのリガンドを使用する特異的な治療法 |
PL2101805T3 (pl) | 2007-01-18 | 2013-04-30 | Merck Patent Gmbh | Ligandy integryn do stosowania w leczeniu nowotworów |
WO2008140724A1 (en) | 2007-05-08 | 2008-11-20 | Schering Corporation | Methods of treatment using intravenous formulations comprising temozolomide |
ES2702365T3 (es) * | 2008-06-19 | 2019-02-28 | Prothix Bv | Uso de anticuerpos antifactor XI para la prevención o el tratamiento de la formación de trombos |
KR20120104491A (ko) | 2009-05-25 | 2012-09-21 | 메르크 파텐트 게엠베하 | 암 치료를 위한 실렌기티드의 연속 투여 |
AU2011278700A1 (en) | 2010-07-16 | 2013-02-28 | Merck Patent Gmbh | Peptide for use in the treatment of breast cancer and/or bone metastases |
KR20140107195A (ko) * | 2011-11-25 | 2014-09-04 | 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 | Snap/clip 태그의 검출용 단일클론 항체 |
CN104114697A (zh) * | 2011-12-09 | 2014-10-22 | 巴斯德研究所 | 多重免疫筛选分析 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407804A (en) * | 1992-05-22 | 1995-04-18 | Applied Genetics Inc. | Assays for O6 -methylguanine-DNA methyltransferase |
-
1992
- 1992-11-27 GB GB929224888A patent/GB9224888D0/en active Pending
-
1993
- 1993-11-23 SG SG1996002679A patent/SG48841A1/en unknown
- 1993-11-29 AU AU55705/94A patent/AU688289B2/en not_active Ceased
- 1993-11-29 CA CA002149867A patent/CA2149867A1/en not_active Abandoned
- 1993-11-29 ES ES94900935T patent/ES2119992T3/es not_active Expired - Lifetime
- 1993-11-29 DE DE69320364T patent/DE69320364T2/de not_active Expired - Fee Related
- 1993-11-29 EP EP94900935A patent/EP0670908B1/en not_active Expired - Lifetime
- 1993-11-29 US US08/436,464 patent/US5817514A/en not_active Expired - Lifetime
- 1993-11-29 AT AT94900935T patent/ATE169680T1/de not_active IP Right Cessation
- 1993-11-29 WO PCT/GB1993/002449 patent/WO1994012660A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO1994012660A1 (en) | 1994-06-09 |
AU688289B2 (en) | 1998-03-12 |
GB9224888D0 (en) | 1993-01-13 |
DE69320364D1 (de) | 1998-09-17 |
US5817514A (en) | 1998-10-06 |
CA2149867A1 (en) | 1994-06-09 |
AU5570594A (en) | 1994-06-22 |
EP0670908B1 (en) | 1998-08-12 |
ATE169680T1 (de) | 1998-08-15 |
EP0670908A1 (en) | 1995-09-13 |
DE69320364T2 (de) | 1998-12-10 |
SG48841A1 (en) | 1998-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69429095D1 (de) | Humanisierte antikoerper | |
DE69840383D1 (de) | Ctl epitope des epstein-barr virus | |
ES2119992T3 (es) | Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). | |
AR248044A1 (es) | Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped. | |
ATE212038T1 (de) | Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung | |
BG104778A (en) | Antibodies against human cd40 | |
UA50708C2 (uk) | Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382 | |
AU2001258567A1 (en) | Humanised antibodies to the epidermal growth factor receptor | |
EP0584715A3 (de) | Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper. | |
DE69128273D1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
DE69322783T2 (de) | Monoklonale Antikörper gegen Glykoprotein P | |
GR3029483T3 (en) | Antibodies against t-cells as therapeutics | |
ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
EP0396505A3 (en) | Monoclonal antibodies specific for an immunoglobulin isotype | |
NO972522L (no) | Monoklonale antistoffer med immunoundertrykkende aktivitet | |
ES8707114A1 (es) | Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa | |
DE59812529D1 (de) | Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2 | |
HK1011924A1 (en) | Monoclonal antibodies to antigens expressed by hematopoietic facilitaroy cells. | |
GB2284608A (en) | 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies | |
ES2000615A6 (es) | Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3" | |
ATE293685T1 (de) | Monoklonaler antikörper gegen ratte beta-2- integrin alpha d untereinheit und entsprechendes hybridoma | |
Rouger et al. | Challenge of Human Monoclonal Antibodies. | |
Seo et al. | Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens | |
Predy | Characterization of novel antigens, detected using monoclonal antibodies raised against tissue from the central nervous system of multiple sclerosis patients | |
HUP0003029A2 (hu) | Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 670908 Country of ref document: ES |